Lincoln National Corp’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-156,225
| Closed | -$234K | – | 1058 |
|
|
2023
Q1 | $234K | Buy |
156,225
+525
| +0.3% | +$788 | ﹤0.01% | 860 |
|
|
2022
Q4 | $182K | Sell |
155,700
-62,000
| -28% | -$72.5K | ﹤0.01% | 877 |
|
|
2022
Q3 | $246K | Sell |
217,700
-33,800
| -13% | -$38.2K | 0.01% | 730 |
|
|
2022
Q2 | $397K | Buy |
251,500
+58,600
| +30% | +$92.5K | 0.01% | 541 |
|
|
2022
Q1 | $297K | Sell |
192,900
-600
| -0.3% | -$924 | 0.01% | 717 |
|
|
2021
Q4 | $474K | Buy |
193,500
+38,900
| +25% | +$95.3K | 0.01% | 541 |
|
|
2021
Q3 | $390K | Buy |
+154,600
| New | +$390K | 0.01% | 585 |
|